Drug: gliclazide Quarter: 2016Q3
Total Drug/Injury Combinations: 95 Number of Pages: 5
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| GLICLAZIDE | Congenital hepatomegaly | 1 | view events |
| GLICLAZIDE | Conjunctival haemorrhage | 1 | view events |
| GLICLAZIDE | Dehydration | 1 | view events |
| GLICLAZIDE | Diarrhoea | 1 | view events |
| GLICLAZIDE | Dizziness | 1 | view events |
| GLICLAZIDE | Drug interaction | 1 | view events |
| GLICLAZIDE | Drug reaction with eosinophilia and systemic symptoms | 1 | view events |
| GLICLAZIDE | Dry gangrene | 1 | view events |
| GLICLAZIDE | Erythema nodosum | 1 | view events |
| GLICLAZIDE | Fixed drug eruption | 1 | view events |
| GLICLAZIDE | Flushing | 1 | view events |
| GLICLAZIDE | Foetal exposure during pregnancy | 1 | view events |
| GLICLAZIDE | Gastric haemorrhage | 1 | view events |
| GLICLAZIDE | Gastric perforation | 1 | view events |
| GLICLAZIDE | General physical health deterioration | 1 | view events |
| GLICLAZIDE | Gingival hypertrophy | 1 | view events |
| GLICLAZIDE | Glycosuria | 1 | view events |
| GLICLAZIDE | Glycosylated haemoglobin increased | 1 | view events |
| GLICLAZIDE | Hepatotoxicity | 1 | view events |
| GLICLAZIDE | Insulin C-peptide decreased | 1 | view events |
Total Drug/Injury Combinations: 95 Number of Pages: 5
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)